Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer
Data from molecular profiles of tumors and tumor associated cells provide a model in which cancer cells can acquire the capability of avoiding immune surveillance by expressing an immune-like phenotype. Recent works reveal that expression of immune antigens (PDL1, CD47, CD73, CD14, CD68, MAC387, CD1...
Saved in:
Main Authors: | Pietro Parcesepe, Guido Giordano, Carmelo Laudanna, Antonio Febbraro, Massimo Pancione |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/6261721 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
by: Francesco Dituri, et al.
Published: (2011-01-01) -
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
by: Ying Zhu, et al.
Published: (2023-01-01) -
Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion
by: Peng Huang, et al.
Published: (2025-01-01) -
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
by: Aiman B. Awan, et al.
Published: (2025-01-01) -
Immune Evasion Strategies of Trypanosoma cruzi
by: Ana Flávia Nardy, et al.
Published: (2015-01-01)